Biodyne Co., Ltd. (KOSDAQ:314930)
South Korea · Delayed Price · Currency is KRW 9,730.00
+70.00 (0.72%)
At close: May 21, 2026
Biodyne Market Cap
Biodyne has a market cap or net worth of 287.52 billion as of May 21, 2026. Its market cap has decreased by -30.30% in one year.
Market Cap
287.52B
Enterprise Value
267.87B
Revenue
4.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
9,730.00
Market Cap Chart
Since March 17, 2021, Biodyne's market cap has increased from 252.12B to 287.52B, an increase of 14.04%. That is a compound annual growth rate of 2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 287.52B | -28.44% |
| Dec 30, 2025 | 401.82B | -16.15% |
| Dec 30, 2024 | 479.20B | 19.24% |
| Dec 28, 2023 | 401.88B | 185.76% |
| Dec 29, 2022 | 140.63B | -31.74% |
| Dec 30, 2021 | 206.02B | -18.28% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 281.02B |
| Celemics | 130.14B |
| BIOBIJOU | 100.50B |
| DENTIS CO.,Ltd | 56.84B |
| Finemedix | 36.66B |
| Genolution | 32.43B |
| TASCOM | 22.28B |
| Sanigen Co. | 13.55B |